New Autoantigen Microarray at Creative Biolabs Achieves Wider Coverage Including Coronavirus

New York, United States – July 26, 2022 /MarketersMEDIA/ —

Autoantigens are linked to the specific adaptive immune response that often leads to autoimmune disease. Consisting of intracellular organelles, nuclear or cytoplasm, they are useful in disease diagnosis. Noticing the potential and raising demand, Creative Biolabs has upgraded the autoantigen microarray technology serving as a high throughput approach in autoantibody profiling.

With the dedication to facilitating the detection of natural autoantibody (NAA) associated diseases and the discovery of new biomarkers, the expert team has promoted the portfolio of autoantigen microarray detection services, which now covers a wide of applications, such as coronaviruses, common allergens, and central nervous system disorders.

* Antigen Microarray Detection for Coronaviruses

The rapidity, specificity, and accuracy of microarray-based detection make it a superior choice for Coronavirus detection. The Creative Biolabs team has successfully designed a 60-mer oligonucleotide microarray for SARS-CoV and has developed a new microarray technique to detect 24 SNP mutations amidst the gene encoding the spike (S) protein of SARS-CoV.

Based on accumulated experience, Creative Biolabs is ready to leverage cutting-edge technologies and platforms to assist clients in designing antigen microarray detection for SARS-CoV-2 coronavirus.

* Antigen Microarray Detection for Common Allergens

The custom service on antigen microarray detection for common allergens can ensure that specific IgE to potentially thousands of allergens can be assayed in parallel with a small amount of serum. A wide range of molecular allergens is covered, including aeroallergens (tree, pollen, etc.), food allergens (peanut, cow’s milk, etc.), and contact allergens (latex).

* Antigen Microarray Detection for Brain and Central Nervous System Disorders

Utilizing antigen microarray to help analyze brain and central nervous system disorders research, covering Alzheimer’s disease (AD), vascular dementia, and Parkinson’s disease (PD), is a trend showing great potential. Creative Biolabs has been focusing on this field for years, establishing a systematical technology platform with verified autoantigens related to nervous system diseases, and is confident in offering customer-satisfied antigen microarray detection services to global clients.

The aforementioned services highlight high throughput and high load with each slide processing up to 15 samples in parallel, high sensitivity of 100-fold more sensitive than ELISA, and small sample volume of as little as 10ul of serum. For every project, the sophisticated project manager will guide clients from custom design to the data report within a short timeframe of about 2 weeks.

Check the official website to learn more about the services and products: https://www.creative-biolabs.com/natural-autoantibody/.

About Creative Biolabs

With an unrelenting drive in bio-science research and industry, Creative Biolabs has successfully developed a new range of natural autoantibody (NAA) platforms to provide fast and convenient NAA services, covering NAA detection, profiling, affinity measurement, and NAA epitope/paratope mapping. In addition, a portfolio of premade or custom NAA products (such as NAA detection assay kits) is also available.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/natural-autoantibody/

Release ID: 89078984

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.